Assignee
PSIOXUS THERAPEUTICS LTD
GB15 patents
Top patents by PatentIndex Score
US10548929B2Feb 4, 2020
Oncolytic adenovirus encoding a therapeutic protein or active fragment
PSIOXUS THERAPEUTICS LTD4 citations82
US9987314B2Jun 5, 2018
Oncolytic adenoviruses armed with heterologous genes
PSIOXUS THERAPEUTICS LTD6 citations81
US10034905B2Jul 31, 2018
Group B adenovirus modified in the E4orf4 region
PSIOXUS THERAPEUTICS LTD9 citations78
US11155622B2Oct 26, 2021
Virus encoding an anti-TCR-complex antibody or fragment
PSIOXUS THERAPEUTICS LTD3 citations71
US10849945B2Dec 1, 2020
Oncolytic adenovirus encoding a B7 protein or active fragment
PSIOXUS THERAPEUTICS LTD3 citations71
US11439678B2Sep 13, 2022
Oncolytic adenoviruses armed with heterologous genes
PSIOXUS THERAPEUTICS LTD1 citations70
US11000559B2May 11, 2021
Oncolytic adenovirus encoding a B7 protein
PSIOXUS THERAPEUTICS LTD2 citations69
US10124028B2Nov 13, 2018
Oncolytic adenovirus encoding a B7 protein or active fragment
PSIOXUS THERAPEUTICS LTD1 citations61
US9115337B2Aug 25, 2015
Chimeric adenoviruses for use in cancer treatment
PSIOXUS THERAPEUTICS LTD1 citations61
US11142580B2Oct 12, 2021
Oncolytic virus and method
PSIOXUS THERAPEUTICS LTD0 citations51
US9234185B2Jan 12, 2016
Chimeric adenoviruses for use in cancer treatment
PSIOXUS THERAPEUTICS LTD0 citations50
US9034344B2May 19, 2015
Chimeric adenoviruses for use in cancer treatment
PSIOXUS THERAPEUTICS LTD0 citations50
US11173186B2Nov 16, 2021
Dosing regime and formulations for type B adenovirus
PSIOXUS THERAPEUTICS LTD0 citations48
US10322152B2Jun 18, 2019
Oncolytic adenovirus encoding a B7 protein
PSIOXUS THERAPEUTICS LTD0 citations48
US10472648B2Nov 12, 2019
Method of making adenovirus and corresponding plasmids
PSIOXUS THERAPEUTICS LTD0 citations38